Streetbeat News

Products Services

TSLA

Tesla is reportedly planning a major overhaul for its Model 3, codenamed 'Highland', which includes exterior and interior updates, new technology features, and improved power efficiency. The launch date remains unclear, but the pricing may remain similar to the current generation due to manufacturing process improvements.

Portfolio Pulse from Benzinga EV Insights

June 22, 2023 | 9:09 pm

SRPT

Sarepta Therapeutics announced the wholesale acquisition cost or gross price of its gene therapy Elevidys for Duchenne Muscular Dystrophy at $3.2 million.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 9:02 pm

SRPT

Sarepta Therapeutics announced the wholesale acquisition cost or gross price of its gene therapy Elevidys for Duchenne Muscular Dystrophy at $3.2 million.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 9:01 pm

GME

HOOD

SONY

The upcoming movie 'Dumb Money' chronicles the GameStop short squeeze saga and features a star-studded cast, including Paul Dano, Pete Davidson, and Seth Rogen. The film is based on Ben Mezrich's book 'The Antisocial Network' and is set to release on September 22, 2023. The movie highlights the role of small investors, Reddit groups, and YouTube videos in taking on the ultrawealthy.

Portfolio Pulse from Chris Katje

June 22, 2023 | 8:45 pm

RKLB

Rocket Lab's upcoming Electron mission will deploy seven satellites into space and attempt to recover the rocket's booster after launch. This marks a significant step towards reusable rocket technology for the company.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 8:36 pm

NVVE

Nuvve Holding Corporation (NASDAQ:NVVE) has launched Astrea AI, an artificial intelligence technology that optimizes revenue from ancillary services for Nordic transmission system operators. Astrea AI forecasts prices and capacity for Nordic primary reserves with 97% accuracy, allowing Nuvve and its fleet customers to maximize revenues.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 8:31 pm

MRNA

Moderna has filed for FDA authorization of its updated COVID-19 vaccine, XBB.1.5, which targets XBB variants. Preliminary clinical data shows a robust immune response, and the company is prepared to deliver the vaccine in time for the fall vaccination season.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 8:06 pm

MGTX

MeiraGTx plans to present an update on its AAV-hAQP1 clinical program for the treatment of grade 2/3 radiation-induced xerostomia on June 27, 2023. The Phase 1 AQUAx clinical trial aims to evaluate the safety of the investigational gene therapy in patients who have remained cancer-free for at least five years.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 8:03 pm

ERAS

Erasca's ERAS-801 has been granted FDA Orphan Drug Designation for the treatment of malignant glioma, including glioblastoma. The drug has also received FDA Fast Track Designation. Initial Phase 1 monotherapy data from the THUNDERBBOLT-1 trial is expected in H2 2023.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 8:02 pm

UBER

Sophia Celentano, a 21-year-old intern, saves thousands of dollars by flying to her workplace in New Jersey once a week from her home in South Carolina. She spends around $100 per week on flights and $100 per week on Uber rides.

Portfolio Pulse from Adam Eckert

June 22, 2023 | 7:45 pm